Overview
Dr. Stapleton is the division chief of oncology and director of pediatric neuro-oncology at Johns Hopkins All Children’s Hospital. Dr. Stapleton joined the hospital in 2007. She has formal training in pediatric neuro-oncology. She received the Armstrong Award for Quality and Patient Safety for Johns Hopkins All Children's in the 2024 Johns Hopkins Medicine Clinical Awards. Dr. Stapleton is on the Pediatric Palliative Care Team at Johns Hopkins All Children’s, and she specializes in symptom control and end of life care. She has been awarded numerous grants for phase I studies for patients with brain and spinal cord tumors as well as clinical research in pediatric palliative care. Dr. Stapleton’s research experience includes investigator-initiated and multi-center research projects. Dr. Stapleton is an associate professor of pediatrics at the University of South Florida and an assistant professor in the department of pediatrics at Johns Hopkins University. Dr. Stapleton completed her medical training at St. Louis University School of Medicine, residency training at Lackland Air Force Base in Texas and fellowship training at Baylor College of Medicine/Texas Children’s Hospital. Dr. Stapleton also served 13 years in the United States Air Force. Dr. Stapleton is a member of the American Board of Pediatrics, the Children’s Oncology Group, the Society of Neuro-Oncology, American Society of Pediatric Hematology/Oncology, and America Academy of Hospice and Palliative Medicine.
Dr. Stapleton is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, Histiocytosis, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 26 peer reviewed articles and participating in 22 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
Locations
Suite 320, Saint Petersburg, FL 33701
12220 Bruce B Downs Boulevard, Tampa, FL 33612
Additional Areas of Focus
Dr. Stapleton has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
22 Clinical Trials
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Dr. Ayala is the director of the Hemophilia and Bleeding Disorders Treatment Center at Johns Hopkins All Children's Hospital. She also is the hematology leader of the Young Women Bleeding Disorders/Menorrhagia Clinic, which focuses on a multidisciplinary approach to bleeding symptoms in girls and young women. Dr. Ayala also is involved in the Immune Dysregulation Clinic, which evaluates patients with autoimmune cytopenias in a multidisciplinary approach. Dr. Ayala joined the hospital in 2000. She was the chair of the Division of Hematology/Oncology between 2013-2017 and also served as interim director for the division between 2015-2016. Dr. Ayala's research experience includes multicenter national and international projects. Dr. Ayala received her medical degree from the University of Puerto Rico School of Medicine, her residency training at the San Juan City Hospital in Puerto Rico and her fellowship training at the Emory University School of Medicine Division of Pediatric Hematology/Oncology. Dr. Ayala is a member of the American Society of Pediatric Hematology/Oncology and the Hemophilia and Thrombosis Research Society. Dr. Ayala is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Hemophilia A, Venous Thromboembolism (VTE), Blood Clots, and Evans Syndrome.
Keyur Donda is a Neonatologist and a Pediatrics provider in Tampa, Florida. Dr. Donda is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are High Blood Pressure in Infants, Bronchopulmonary Dysplasia, Premature Infant, Gastrostomy, and Splenectomy. Dr. Donda is currently accepting new patients.
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Dr. Metts specializes in pediatric hematology/oncology in the Johns Hopkins All Children's Cancer & Blood Disorders Institute. He sees patients on our main campus in St. Petersburg and at the Johns Hopkins All Children’s Outpatient Care Center in Tampa. He joined the hospital in 2016. He received his medical degree from the University of South Carolina School of Medicine and completed an internship and residency in pediatrics at Johns Hopkins All Children’s Hospital through the University of South Florida Morsani School of Medicine. Dr. Metts then trained at Emory University School of Medicine as a pediatric hematology/oncology fellow. His clinical interests include sarcomas, rare solid tumors, and Phase 1 and Phase 2 trials for pediatric solid tumors. Dr. Metts is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma, and Adult Soft Tissue Sarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MedulloblastomaDr. Stapleton isDistinguished. Learn about Medulloblastoma.
- Advanced
- Denys-Drash Syndrome (DDS)Dr. Stapleton isAdvanced. Learn about Denys-Drash Syndrome (DDS).
- Embryonal Tumor with Multilayered Rosettes
- Ewing SarcomaDr. Stapleton isAdvanced. Learn about Ewing Sarcoma.
- GliomaDr. Stapleton isAdvanced. Learn about Glioma.
- HepatoblastomaDr. Stapleton isAdvanced. Learn about Hepatoblastoma.
- HistiocytosisDr. Stapleton isAdvanced. Learn about Histiocytosis.
- Experienced
- Adult Soft Tissue SarcomaDr. Stapleton isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone Marrow AspirationDr. Stapleton isExperienced. Learn about Bone Marrow Aspiration.
- NeuroblastomaDr. Stapleton isExperienced. Learn about Neuroblastoma.
- NeurofibromatosisDr. Stapleton isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Stapleton isExperienced. Learn about Neurofibromatosis Type 1 (NF1).
- OsteosarcomaDr. Stapleton isExperienced. Learn about Osteosarcoma.